Genus Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Genus Capital Management's AMGN Position: Q2 2026 in Review
Genus Capital Management reduced its Amgen (AMGN) stake by 18% in Q2 2026, selling an estimated $2.8M and leaving 36,237 shares worth $13.1M. The position accounts for 1.29% of the portfolio, ranked #21.
Genus Capital Management first reported a position in AMGN in Q2 2023 and has held it in 8 quarters since. The position peaked at $15.6M in Q1 2026. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Genus Capital Management held 36,237 shares of Amgen worth $13.1M as of Q2 2026.
- Genus Capital Management sold 8,190 Amgen shares in Q2 2026, an estimated $2.8M.
- Amgen made up 1.29% of Genus Capital Management's portfolio in Q2 2026, its #21 holding.
- Genus Capital Management first reported a position in Amgen in Q2 2023 and has held it in 8 quarters since.
- Genus Capital Management's Amgen position peaked at $15.6M in Q1 2026.
- 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.